Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

265 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Adverse Event Compensation in China: A Growing Patchwork of Provincial Rules

    Success in campaigns of prevention and control of epidemics will in no way veil the significance of adverse events following immunization ("AEFIs").
    ChinaFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    Medical devices production enterprises are facing higher supervision

    This series of regulatory actions demonstrate efforts to strengthen the administration of medical devices and equipment.
    ChinaFood, Drugs, Healthcare, Life Sciences
    King & Wood Mallesons
    King & Wood Mallesons
Article

Individual Income Tax Exemption On The Commercial Health Insurance Premium

The commercial health insurance scheme should be approved by the provincial finance, taxation and insurance supervision departments.
ChinaTax
Grant Thornton
Grant Thornton
  • Article

    关于专利、商标、集成电路布图设计受疫情影响相关期限事项的公告

    为落实党中央、国务院防控新型冠状病毒感染肺炎疫情的决策部署,切实维护受疫情影响的当事人办理专利、商标、集成电路布图设计等事务
    ChinaIntellectual Property
    AFD China
    AFD China
  • Article

    China Addresses the Problem of Fake Food

    In the last edition of this update, we featured the Hong Kong Government's public consultation on a nutrition labelling scheme for pre-packaged foods. Since that article a disturbing related issue has emerged in Hong Kong and mainland China. Most people are familiar with the trade in counterfeit items all over the world such as watches, computer games, DVDs and clothing. Whilst this is a major concern for multi-national and local companies who wish to protect their intellectual property righ
    ChinaEnergy and Natural Resources
    Lovells
    Lovells
  • Article

    China's New Draft Administrative Measures For Management Of Medical Representatives

    On November 28, 2024, China's National Medical Products Administration (NMPA, 国家药品监督管理局), China's equivalent of the U.S. Food and Drug Administration...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    China Boosts Medical Innovation For Public Health

    China will accelerate the development of core medical technologies and innovative drugs targeting common and complex diseases, including cardiovascular conditions...
    ChinaFood, Drugs, Healthcare, Life Sciences
    AFD China
    AFD China
  • Article

    China's New Regulatory Data Protection Regime Becomes Effective Immediately

    China's National Medical Products Administration has introduced a groundbreaking regulatory data protection framework that grants up to six years of clinical data exclusivity for pharmaceuticals.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    China’s Revised Regulations on the Supervision and Administration of Medical Devices: New Supervisory System and Increased Penalties

    The Revised Regulations will come into effective on 1 June 2014, presenting some major changes.
    ChinaFood, Drugs, Healthcare, Life Sciences
    King & Wood Mallesons
    King & Wood Mallesons
  • Article

    The New Draft Administrative Measures For Management Of Medical Representatives

    On November 28, 2024, China's National Medical Products Administration (NMPA, 国家药品监督管理局), China's equivalent of the U.S. Food and Drug Administration,
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    The Ministry Of Human Resources And Social Security Of The People's Republic Of China: The Newly Added 20 Medical Rehabilitation Projects Should Be Included In The Range Of Basic Medical Insurance Payment (In Chinese)

    中国经济网北京3月22日讯(记者韩秉志)近日,人力资源和社会保障部、国家卫生计生委、民政部、财政部、中国残联等部门联合印发了...
    ChinaInsurance
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    保持社交距离时期的个人隐私和安全警戒

    在这个充满挑战的时刻,考虑到我们的朋友、家人和同事的健康,采用预防措施当然是最重要的。虽然我们的生活和工作被以各种方式打乱,
    ChinaCoronavirus (COVID-19)
    Lawson Lundell LLP
    Lawson Lundell LLP
  • Article

    China Provides "Fast Track" For Certain New Drug Applications

    The State Food and Drug Administration ("SFDA") has been for long experiencing a shortage of manpower to efficiently deal with drug applications in a timely manner.
    ChinaFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    Rabbits Rejoice – End of PRC Animal Testing Requirements Nears

    Some brands are not found in China because some cosmetics and body care companies are against animal testing.
    ChinaFood, Drugs, Healthcare, Life Sciences
    King & Wood Mallesons
    King & Wood Mallesons
  • Article

    Relaxation Of Long-Standing Restrictions On Foreign Investment In The Healthcare Sector In China

    The demand for medical services in China is growing, with the country's ageing population set against its potential for economic development.
    ChinaFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    China Revises Good Clinical Practice Rules

    China's revised Good Clinical Practice for Drug Trials took effect on 1 September 2026, fundamentally reshaping the regulatory landscape for clinical trials by aligning domestic requirements with ICH E6(R3) standards. The new framework introduces streamlined regulations spanning just 54 articles across six chapters, while establishing comprehensive data governance requirements and clarifying ultimate accountability for sponsors, principal investigators, and clinical trial institutions. Companies conducting
    ChinaFood, Drugs, Healthcare, Life Sciences
    BUREN
    BUREN
  • Article

    Key 2015 Healthcare And Pharmaceutical Policies

    We have analyzed drug policies with regard to drug pricing and the centralized procurement of drugs in the previous Key 2015 Healthcare and Pharmaceutical Policies: Pharmaceuticals.
    ChinaFood, Drugs, Healthcare, Life Sciences
    King & Wood Mallesons
    King & Wood Mallesons
  • Article

    CFDA Solicits Comments On Drug Registration Rules

    Unlike the DRR, the Revisions do not distinguish an international multicenter study from a drug registration study.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China’s Drug Trial Data Protection Regime Is Now Formally In Force

    China's National Medical Products Administration has officially implemented new drug trial data protection measures, establishing a comprehensive framework that grants varying protection periods based on innovation levels.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Lusheng Law Firm
    Lusheng Law Firm
  • Article

    Analysis Of Regulations For Approval Of Digital Therapeutics

    China's digital therapeutics (DTx) business has vaulted into the limelight as a major new investment target of the healthcare sector, with a number of domestic companies joining...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Jingtian & Gongcheng
    Jingtian & Gongcheng
  • Showing 81–100 of 265 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics